Fierce Biotech April 25, 2024
A Swiss startup called Risklick has launched artificial intelligence software for clinical trials that the company claims can reduce development time and costs by as much as 35%, according to an April 23 release.
The software, Protocol AI, is designed to cut down on the time it takes to come up with a study protocol—a process that takes an average of a year in total to complete, by Risklick’s estimates. The company’s technology uses natural language processing and large language models to analyze historical trial data, helps trial sponsors set variables and benchmarks, and then automatically drafts the protocol using generative AI.
Risklick already has deals...
Today's Sponsors
Today's Sponsor